Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000004088
- Lead Sponsor
- Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The following patients were excluded 1)Allegic history to interferon preparations 2)Autoimmune hepatitis,alcoholic liver injury,or chronic liver diseases with other underlying causes 3)Liver cirrhosis,decompensated liver diseases 4) Abnormal thyroid function 5)Concomitant herbal medication of Sho-saikoto 6) history of interstitial pneumonia 7) Women of childbearing potential and pregnancy, lactating woman 8)severe depression 9)Allergic to vaccine or biological preparations 10)Other conditions considered inappropriate by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method